Intravitreal triamcinolone acetonide in management of ocular toxoplasmosis in an HIV patient: a case report.
Abhishek C
AC
Bawdekar
Animesh
A
Jindal
Milan
M
Shah
Avinash
A
Pathengay
Milan
M
Shah
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000469:parasitology; D000328:Adult; D000913:Antibodies, Protozoan / Q000097:blood; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D016867:Immunocompromised Host; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D058449:Intravitreal Injections; D008297:Male; D012173:Retinitis / Q000188:drug therapy* / Q000469:parasitology; D014126:Toxoplasmosis, Ocular / Q000188:drug therapy* / Q000469:parasitology; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*; D014792:Visual Acuity
D000913:Antibodies, Protozoan; D005938:Glucocorticoids; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D014222:Triamcinolone Acetonide